Masters of Scale
Masters of Scale

$300m in year two. The controversy came free, with David Protein’s Peter Rahal

David protein bars went from startup to one of the hottest consumer products in America in under two years. But the ride has been anything but smooth. Founder and CEO Peter Rahal joins Rapid Response to talk about building a breakout brand through lawsuits, a Jeffrey Epstein association, and the kin

Featured Speakers

WaitWhat HostPeter Rahal Guest

Topics Discussed

Episode Summary

Executive Summary: Bob Safian interviews David CEO Peter Rahal about the fast rise of his protein bar brand and its controversial but effective strategy. Rahal explains how David uses EPG, a hard-to-digest fat, to maximize protein and minimize calories, why vertical integration was needed, how the company handled lawsuits and the Epstein-linked departure of its science chief, and why he believes protein and high-protein products have long-term staying power across bars and ice cream.

Main Topics: David’s origin and rapid growth (Priority: 5/5): Rahal describes David as a new protein-bar brand built from first principles and already on track for extraordinary revenue in its second year. EPG as the core product innovation (Priority: 5/5): The company’s differentiator is EPG, a modified triglyceride used to provide fat-like texture with minimal digestible calories, enabling unusually high protein-to-calorie ratios. Vertical integration and ingredient control (Priority: 4/5): Rahal explains why David bought Epigee, the EPG manufacturer, arguing the ingredient company needed scale and supply certainty, not just external licensing. Controversy, lawsuits, and brand attention (Priority: 4/5): The conversation covers competitor lawsuits, a labeling class action, and Rahal’s view that controversy is often a natural byproduct of innovation and can increase awareness. Jeffrey Epstein fallout and Peter Attia (Priority: 4/5): Rahal discusses the departure of chief science officer Peter Attia after his name appeared in Epstein-related court documents and frames the move as necessary and victim-centered. Protein’s future and GLP-1 tailwinds (Priority: 5/5): Rahal argues protein is becoming more central to nutrition, not less, and sees GLP-1 adoption as reinforcing demand for protein and fiber-rich foods. Brand positioning, gender, and aesthetics (Priority: 3/5): Rahal claims protein products should not be feminized and argues that David’s masculine name and aesthetic broaden appeal, especially among men, while still attracting women.

Key Arguments: David is designed from first principles as a protein delivery system: maximize protein, minimize calories, preserve taste and texture. EPG is the best fat system for this purpose because it behaves like fat in the mouth but is hard for the body to digest, lowering caloric impact. Buying Epigee was a practical vertical-integration move to solve EPG supply constraints and support demand growth, not an anti-competitive scheme. The lawsuits and labeling challenges were part of the normal friction around novel products and, in Rahal’s view, may have increased awareness of the brand. Peter Attia’s exit after Epstein-related documents surfaced was framed as a necessary separation to align with victims and protect the company. Protein is not a fad in Rahal’s view; it is becoming more central to diets, especially as GLP-1 drugs increase the need to preserve muscle with adequate protein intake. David’s branding choices are meant to avoid alienating men while still appealing to women through strong design and aesthetic cues.

Data Points: Revenue run rate: More than $300 million - Rahal says David is on track to exceed this in its second full year after launching in 2024. Launch year: 2024 - David launched in 2024. Protein per bar: 28 grams - Shown on the David bar package as part of the product’s high-protein positioning. Calories per bar: 150 calories - Used to illustrate the unusually low-calorie profile of the bar. Sugar per bar: No sugar - Highlighted as a key nutritional claim for David bars. Acquisition price for prior company: $600 million - Bob notes Rahal previously sold RX Bars to Kellogg for this amount. Retail distribution: 16,000+ retailers - Rahal says David is now sold in roughly this many retailers. Female-to-male customer mix: 60/40 female to male - Rahal says the product’s customer base is actually majority female despite its masculine branding. Bar history: 1990s - Rahal references earlier fat-substitute attempts, including Olestra, from this era.

Pivotal Quotes: "Anything that's really innovative and new in our culture, in the world, gets misunderstood." — Peter Rahal: Rahal uses this to frame the lawsuits and scrutiny around David as a normal consequence of innovation. "All things equal, you'd rather have people talking about you than not." — Peter Rahal: He argues that controversy can benefit brand awareness and education over time. "If you were to give a gender to a protein bar, it would be a man." — Peter Rahal: Rahal explains his view that David’s masculine branding helps avoid alienating male consumers.

Implications: The episode suggests that food startups can win by pairing hard science with aggressive branding and supply control, but innovation also invites scrutiny. It also signals a durable market for protein-forward products, especially as GLP-1 use reshapes nutrition habits.

🔓 Sign Up for Unlimited Episode Search

About Masters of Scale

On Masters of Scale, iconic business leaders share lessons and strategies that have helped them grow the world's most fascinating companies. Founders, CEOs, and dynamic innovators join candid conversations about their triumphs and challenges with a set of luminary hosts, including founding host Reid Hoffman (LinkedIn co-founder and Greylock partner). From navigating early prototypes to expanding brands globally, Masters of Scale provides priceless insights to help anyone grow their dream ente...

View all episodes from Masters of Scale